» Articles » PMID: 26446232

A National Survey to Systematically Identify Factors Associated With Oncologists' Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?

Overview
Journal Oncologist
Specialty Oncology
Date 2015 Oct 9
PMID 26446232
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: End-of-life discussions (EOLds) occur infrequently until cancer patients become terminally ill.

Methods: To identify factors associated with the timing of EOLds, we conducted a nationwide survey of 864 medical oncologists. We surveyed the timing of EOLds held with advanced cancer patients regarding prognosis, hospice, site of death, and do-not-resuscitate (DNR) status; and we surveyed physicians' experience of EOLds, perceptions of a good death, and beliefs regarding these issues. Multivariate analyses identified determinants of early discussions.

Results: Among 490 physicians (response rate: 57%), 165 (34%), 65 (14%), 47 (9.8%), and 20 (4.2%) would discuss prognosis, hospice, site of death, and DNR status, respectively, "now" (i.e., at diagnosis) with a hypothetical patient with newly diagnosed metastatic cancer. In multivariate analyses, determinants of discussing prognosis "now" included the physician perceiving greater importance of autonomy in experiencing a good death (odds ratio [OR]: 1.34; p = .014), less perceived difficulty estimating the prognosis (OR: 0.77; p = .012), and being a hematologist (OR: 1.68; p = .016). Determinants of discussing hospice "now" included the physician perceiving greater importance of life completion in experiencing a good death (OR: 1.58; p = .018), less discomfort talking about death (OR: 0.67; p = .002), and no responsibility as treating physician at end of life (OR: 1.94; p = .031). Determinants of discussing site of death "now" included the physician perceiving greater importance of life completion in experiencing a good death (OR: 1.83; p = .008) and less discomfort talking about death (OR: 0.74; p = .034). The determinant of discussing DNR status "now" was less discomfort talking about death (OR: 0.49; p = .003).

Conclusion: Reflection by oncologists on their own values regarding a good death, knowledge about validated prognostic measures, and learning skills to manage discomfort talking about death is helpful for oncologists to perform appropriate EOLds.

Implications For Practice: Oncologists' own perceptions about what is important for a "good death," perceived difficulty in estimating the prognosis, and discomfort in talking about death influence their attitudes toward end-of-life discussions. Reflection on their own values regarding a good death, knowledge about validated prognostic measures, and learning skills to manage discomfort talking about death are important for improving oncologists' skills in facilitating end-of-life discussions.

Citing Articles

Physicians' knowledge, attitudes and practices on advance care planning for patients with advanced cancer in a National University Hospital in the Philippines.

Estreller S, Pilapil J, Ting F, Real I, Dee E Ecancermedicalscience. 2024; 18:1725.

PMID: 39421161 PMC: 11484654. DOI: 10.3332/ecancer.2024.1725.


Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer.

Hasegawa T, Okuyama T, Uemura T, Matsuda Y, Otani H, Shimizu J Support Care Cancer. 2024; 32(7):421.

PMID: 38856947 DOI: 10.1007/s00520-024-08630-z.


Preferences of bereaved family members on communication with physicians when discontinuing anticancer treatment: referring to the concept of nudges.

Yoshida S, Hirai K, Ohtake F, Masukawa K, Morita T, Kizawa Y Jpn J Clin Oncol. 2024; 54(7):787-796.

PMID: 38553776 PMC: 11228860. DOI: 10.1093/jjco/hyae038.


The trajectory of prognostic cognition in patients with advanced cancer: is the traditional advance care planning approach desirable for patients?.

Hasegawa T, Okuyama T, Akechi T Jpn J Clin Oncol. 2024; 54(5):507-515.

PMID: 38336476 PMC: 11075734. DOI: 10.1093/jjco/hyae006.


Timing of prognostic discussions in people with advanced cancer: a systematic review.

Nahm S, Subramaniam S, Stockler M, Kiely B Support Care Cancer. 2024; 32(2):127.

PMID: 38261070 DOI: 10.1007/s00520-023-08230-3.


References
1.
Wright A, Keating N, Balboni T, Matulonis U, Block S, Prigerson H . Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol. 2010; 28(29):4457-64. PMC: 2988637. DOI: 10.1200/JCO.2009.26.3863. View

2.
Reilly B, Magnussen C, Ross J, Ash J, Papa L, Wagner M . Can we talk? Inpatient discussions about advance directives in a community hospital. Attending physicians' attitudes, their inpatients' wishes, and reported experience. Arch Intern Med. 1994; 154(20):2299-308. View

3.
Whippen D, Canellos G . Burnout syndrome in the practice of oncology: results of a random survey of 1,000 oncologists. J Clin Oncol. 1991; 9(10):1916-20. DOI: 10.1200/JCO.1991.9.10.1916. View

4.
Bradley E, Cramer L, Bogardus Jr S, Kasl S, Johnson-Hurzeler R, Horwitz S . Physicians' ratings of their knowledge, attitudes, and end-of-life-care practices. Acad Med. 2002; 77(4):305-11. DOI: 10.1097/00001888-200204000-00009. View

5.
Markson L, Clark J, Glantz L, Lamberton V, Kern D, STOLLERMAN G . The doctor's role in discussing advance preferences for end-of-life care: perceptions of physicians practicing in the VA. J Am Geriatr Soc. 1997; 45(4):399-406. DOI: 10.1111/j.1532-5415.1997.tb05162.x. View